https://www.bloomberg.com/quote/TOPG:SP

Topglov sgx down 10% !!! Good news or bad news for Supermx ?? Tomorrow morning runnnn.....

Topglov sgx down 10% !!!!

https://www.bloomberg.com/quote/TOPG:SP

Black day in bursa... luckily didn't catch the falling knife. Bought meridian and AT-WC instead.

Black day in bursa...hang until tomorrow...watlauer

7.8 % in sgx, how many % in bursa ? boh chao si

https://klse.i3investor.com/m/blog/stocknewsforward/2020-07-16-story-h1510574623.jsp

Runnnn......

https://klse.i3investor.com/m/blog/stocknewsforward/2020-07-16-story-h1510574623.jsp

Runnnn.....

All big four limit down tomorrow ? Hopefully not.

If bursa hang until tomorrow Topglov will definitely limit down with Supermx

If don't work 23 hours a day how to meet their client's demands that needed billions of gloves and with limited workforce.

overmars what are your intentions to worsen this counter greddy? are u trying to buy cheap share when the price drop? even 2015 and 2019 news also u korek balik... baik hang masuk politic jadi kaki korek

Halo overmars....if I want to buy cheap, there are so many choices in bursa, why must I chose Anzo ? Even AT is much cheaper than Anzo and also involved in glove business. My intention just to highlight the untrustworthy of this Anzo in execute their contracts. If it happened long time ago means it could happen again now with so many questionable in their copper deal and acquisition of the glove company. If someone lie to you do you still trust him ?

20 cents coming soon

Vaccine coming...buy GENM

Another contract terminated...very good record

https://www.theedgemarkets.com/article/anzos-rm153m-malacca-construction-contract-terminated

Contract can be terminated any time

https://www.propertyguru.com.my/property-news/2015/3/86718/harvest-court-sagajuta-terminate-rm129mil-medium-cost-apartment-contract

If the story about Anzo is true, why the three idiots new bosses sold off all their Anzo so fast ?

Yes sailang Anzo...go to holland faster. Prebiu.com ? This type of write up also believe ? If theedgedaily maybe still can believe.

Supermx most fear 'creature' is on its way... hope not appear before qr in August.

Wow still got many small fish here believe in Anzo. Even the price movement today tell you that not all ppl believe their story. Save your hard-earned money !

Vsolar now is 4 cents...do you think the price could go down to 1-2 cents ? Even Fintec dispose all his holding, the price will stay around 3-4 cents in the immediate term and rebound strongly towards September when the solar contract is around the corner. Just buy and keep. If drop to 3 cents can buy more and keep until September. The warrant can buy at 1-1.5 cents (lowest possible is 0.5 cents).

Buyers still in the process of accumulating meridian share. Most selling absorbed by strong support from buyers. A good sign ahead.

Slow and steady.... going well on road to 20 cents soon.

Big sharks continue their unloading again tomorrow ? Big sharks don't wait until qr to unload. As long as still got big profit, they will continue to dump Topglov. Big sharks just waiting to swallow small fish, not long term players. BEWARE !

Big sharks continue their unloading again tomorrow ? Big sharks don't wait until qr to unload. As long as still got big profit, they will continue to dump Supermx. Big sharks just waiting to swallow small fish, not long term players. BEWARE !

Current liabilities more than current assets by 146 million (group) and 18.8 million (company).

PN17 ? Like what happened to Airasia.

Vsolar now cash rich company after the right issue so Vsolar could participate in LSS@MEnTARI without any problems.

Don't worry, after Fintec finished selling, Vsolar will shoot up again. TP 0.10 by September.

Year to remember or year to forget ?

Big sharks try to lure back small fish so that they can unload their remaining holdings... don't fall into their trap again

Don't be greedy...got profit sell, later if drop can buy back, if still go up then say goodbye and move on with other stocks.

Don't be greedy...got profit sell, later if drop can buy back, if still go up then say goodbye and move on with other stocks

Good ! Later US and UK impose more trading restrictions on goods and services from China and HK, then China retaliates back then US take extra actions then.....bad for world economy

The anak also slowly heading to zero with the expired date nearer and nearer. Mother also no energy to go higher because of the bosses and unfavourable exchange rate.

Today price steady.... ready to move higher

Buy now wait for September good news...big solar contract from gomen

Sell Topglov buy Supermx

Team B is winning, Team A is fighting very hard but still far behind

Buy buy buy... help big shark push up the price

Team B is in control...Team A fighting !

Good news to those in Team B. Vaccine coming very very soon.


CHICAGO - Moderna Inc's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday.

No study volunteers experienced a serious side effect, but more than half reported mild or moderate reactions such as fatigue, headache, chills, muscle aches or pain at the injection site.

These were more likely to occur after the second dose and in people who got the highest dose, the team reported in the New England Journal of Medicine.

Moderna shares jumped more than 15% in after-hours trading on Tuesday.

Moderna was the first to start human testing of a vaccine for the novel coronavirus on March 16, some 66 days after the genetic sequence of the virus was released.

Experts say a vaccine is needed to put an end to the pandemic that has sickened millions and caused nearly 575,000 deaths worldwide.

"The world urgently needs vaccines to protect against COVID-19," said Dr Lisa Jackson of Kaiser Permanente Washington Health Research Institute in Seattle and lead author of the study.

The federal government is supporting Moderna's vaccine with nearly half a billion dollars and has chosen it as one of the first to enter large-scale human trials. A successful vaccine could be a turning point for Cambridge, Massachusetts-based Moderna, which has never had a licensed product.

Moderna's shot, mRNA-1273, uses ribonucleic acid (RNA) - a chemical messenger that contains instructions for making proteins. When injected into people, the vaccine instructs cells to make proteins that mimic the outer surface of the coronavirus, which the body recognises as a foreign invader, and mounts an immune response against.

The results released on Tuesday involved three doses of the vaccine, tested in groups of 15 volunteers aged 18-55 who got two shots, 28 days apart. The groups tested 25, 100 or 250 micrograms of the vaccine.

The team reported that individuals who got two doses of the vaccine had high levels of virus-killing neutralizing antibodies that exceeded the average levels seen in people who had recovered from COVID-19.

Adverse events after the second dose occurred in seven of the 13 volunteers who got the 25-microgram dose, all 15 participants who received the 100 microgram dose and all 14 who got the 250 microgram dose. In the highest-dose group, three patients had severe reactions such as fever, chills, headache or nausea. One of these had a fever of 103.28 Fahrenheit (39.6 C).

"We didn't see any events that are characterized as serious adverse events," Jackson said, referring to reactions that require hospitalization or result in death.

In June, Moderna said it selected the 100-microgram dose for its late-stage study to minimize adverse reactions.

At that dose, Moderna said the company is on track to deliver about 500 million doses per year, and possibly up to 1 billion doses per year, starting in 2021, from the company's internal U.S. manufacturing site and strategic collaboration with Swiss drugmaker Lonza.

"It's a good first step," said Dr William Schaffner, a vaccine expert at Vanderbilt University Medical Center who was not involved in the study.

"There's nothing here that would inhibit one from going ahead to the Phase 2/Phase 3 trials," he said. "A little fatigue and headache and myalgia (muscle pain) and pain at the injection site is a small price to pay for protection against COVID-19."

In April, Moderna expanded the Phase 1 trial to include adults over 55, who are more at risk of serious disease, with the aim of enrolling 120 volunteers. Moderna said it will follow study volunteers for a year after the second shot, to look for side effects and check how long immunity lasts.

A very bad news for those who doing businesses in HK.

Buy mother 0.04 and anak 0.02 this September surely double the investment

China is in the lead in producing world first vaccine against covid-19 follow by Japan, Korea, US, Russia and UK. Good news for Supermx and Topglov.

Yes, hold tight tight, even drop to RM8 also hold tight tight until qr release. If qr not as good as thought also hold tight tight even drop to RM5

KWAP wanted to buy low so that later can sell higher after Malakof went past 1.00

Don't worry, Asiabio Capital will push it back to at least 5-6 cents because they also wait for higher price to unload their holding.

shernlee i cant see what so good about this company...becareful with this director..con guy man..

Thanks for the advice...but this time looks real because the price moved from 7 cents to 13 cents with gradual pace, means no sharks involved, only genuine buyer.

Yes buy and keep...by the time Anzo and AT be able to produce their gloves, vaccine already been found, covid-19 slowly disappear, and prices of gloves slump. No point put your hard-earned money in danger.